Metastatic Bone Disease Secondary to Bronchial Adenocarcinoma in a Patient with Paget’s Disease of the Bone
Keywords:
Paget’s disease of the bone, bronchial adenocarcinoma, metastatic bone diseaseAbstract
A 69-year-old female complained of intermittent left hip pain for the past 3 years. Biochemical tests revealed normal serum calcium and phosphorus with markedly raised alkaline phosphatase. MRI of the hip revealed extensive marrow signal abnormalities at the left pelvic bone, while CT of the thorax revealed a spiculated lung nodule at the left lower lung lobe. In order to diagnose either primary, metastatic bone tumour or Paget’s disease of the bone (PDB), an open biopsy of the left iliac bone was performed. The histopathology of bone biopsy of the left iliac bone was consistent with PDB. A CT guided biopsy of the lung mass done later revealed adenocarcinoma of the lung. She had 18F-FDG PET-CECT Scan for staging evaluation and result was suggestive of new bony metastases. Patient was started on IV Zoledronic acid for treatment of the PDB. In view of the stage 4 lung adenocarcinoma with bony metastases, patient was scheduled for palliative chemotherapy.
Downloads
References
Selby PL, Davie MW, Ralston SH, et al. Guidelines on the management of Paget's disease of bone. Bone. 2002;31(3):366–73. PMID: 12231408.
Weinstein SL, Buckwalter JA, eds. Turek’s Orthopedics: Principles and their application, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 1994.
Hadjipavlou A, Lander P. Paget’s disease of the bone of the spine. J Bone Joint Surg Am. 1991;73(9):1376–81. PMID: 1833408.
Soo YS, Singh J. Paget’s disease of bone (osteitis deformans) amongst the West Malaysians. Aust Radiol. 1972;16(2):152. PMID: 4635265.
Rai NP, Anekar J, Mustafa SM, Divakar DD. Paget’s disease with craniofacial and skeletal bone involvement. BMJ Case Reports. 2016. https://doi.org/ 10.1136/bcr-2016-216173.
Roodman GD, Windle JJ. Paget disease of bone. J Clin Invest. 2005;115(2):200–8. PMID: 15690073. PMCID: PMC546434. https://doi.org/10.1172/JCI24281.
Koval KJ. Bone metabolism and metabolic bone diseases. In: Rosier RN, Bukata SV, eds. Orthopedic Knowledge Update 7. Philadelphia: American Academy of Orthopedic Surgeons, 2002.
Hadjipavlou A, Gaitanis IN, Kontakis GM. Paget’s disease of the bone and its management. J Bone Joint Surg Br 2002;84(2):160–9. PMID: 11922354.
Singer FR, Bone HG 3rd, Hosking DJ, et al. Paget’s disease of bone: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99(12):4408-22. PMID: 25406796. https://doi.org/ 10.1210/jc.2014-2910.
Schneider D, Hofmann MT, Peterson JA. Diagnosis and treatment of Paget’s disease of bone. Am Fam Physician. 2002:65(10):2069-72. PMID: 12046775.
Siris ES. Paget disease of bone. In: Becker KL (ed). Principles and practice of endocrinology and metabolism, 3rd ed. Lippincott Williams & Wilkins Company, Philadelphia, 2002.
Coleman RE. Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001; 27(3):165-76. PMID: 11417967. https://doi.org/10.1053/ctrv.2000.0210.
Kanis JA. Pathophysiology and treatment of Paget’s disease of bone. London, UK: Martin Dunitz Publishers, 1991.
Eekhoff ME, Zwinderman AH, Haverkort DM, Cremers SC, Hamdy NA, Papapoulos SE. Determinants of induction and duration of remission of Paget’s disease of bone after bisphosphonate (olpadronate) therapy. Bone. 2003;33(5):831-8. PMID: 14623059.
Reid IR, Miller P, Lyles K, et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease of the bone. N Engl J Med. 2005;353(9):898–908. PMID: 16135834. https://doi.org/10.1056/NEJMoa044241.
Reid IR, Lyles K, Su G, et al. A single infusion of zoledronic acid produces sustained remissions in Paget disease: Data to 6.5 years. J Bone Miner Res. 2011;26(9):2261-70. PMID: 21638319. https://doi.org/10.1002/jbmr.438.
Lyles KW, Colón-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl JMed. 2007;357(18):1799–809. PMID: 17878149. PMCID: PMC2324066. https://doi.org/10.1056/NEJMoa074941.
Shetty S, Shetty S, Prabhu AJ, Kapoor N, Hepzibah J, Paul TV. An unusual presentation of metastatic bone disease in a subject with Paget’s disease of bone. J Family Med Prim Care. 2016;5(2):488-90. PMID: 27843872. PMCID: PMC5084592. https://doi.org/10.4103/2249-4863.192326.
Ilincić B, Crnobrnja V, Mijović R, Zeravica R, Jakovljević A, Kadić V. Polyostotic Paget's disease of bone: Diagnostic dilemma in detection of bone metastases from prostate cancer. Med Pregl. 2012;65(7-8):337–40. PMID: 2292456.
Roberts JA. Paget's disease and metastatic carcinoma. A case report. J Bone Joint Surg Br. 1986;68(1):22–3. PMID: 3941136.
Sonoda LI, Balan KK. Co-existent Paget's disease of the bone, prostate carcinoma skeletal metastases and fracture on skeletal scintigraphy-lessons to be learned. Mol Imaging Radionucl Ther. 2013;22(2):63–5. PMID: 24003400. PMCID: PMC3759312. https://doi.org/10.4274/Mirt.135.
Nebot Valenzuela E, Pietschmann P. Epidemiology and pathology of Paget’s disease of bone – A review. Wien Med Wochenschr. 2017;167(1-2):2-8. PMID: 27600564. PMCID: PMC5266784. https://doi.org/10.1007/s10354-016-0496-4.
Seitz S, Priemel M, Zustin J, et al. Paget’s disease of bone: Histologic analysis of 754 patients. J Bone Miner Res. 2009;24(1):62-9. PMID: 18767930. https://doi.org/10.1359/jbmr.080907.
Cook GJ, Maisey MN, Fogelman I. Fluorine-18-FDG PET in Paget’s disease of the bone. J Nucl Med. 1997;38(9):1495-7. PMID: 9293817.
Mena LM, Hernández AC, Gallego M, Martínez T, Contreras JF. Incidental detection of Paget disease on 18F‑FDG PET/CT scan in a patient with rectal cancer. Rev Esp Med Nucl Imagen Mol. 2013;32(2):117‑8. PMID: 23177337 https://doi.org/10.1016/j.remn.2012.03.004.
Mahmood S, Martinez de Llano SR. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT. Clin Nucl Med. 2008;33(7):510-2. PMID: 18580246. https://doi.org/0.1097/RLU.0b013e318177928a
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
